期刊文献+

Wnt3a基因修饰减轻阿糖胞苷诱导的小鼠骨髓间充质干细胞损伤的体外研究 被引量:4

In Vitro Effects of Wnt3a Gene Modification on Mitigating Damage of Mouse Bone Marrow Mesenchymal Stem Cells Induced by Ara-C
下载PDF
导出
摘要 本研究探讨Wnt3a基因修饰对小鼠骨髓间充质干细胞(MSC)抗阿糖胞苷损伤的作用。通过重组腺病毒系统感染小鼠MSC,建立能够稳定高效表达Wnt3a基因的基因修饰MSC;在体外培养体系中加入不同浓度的阿糖胞分别诱导对基因修饰MSC与未经基因修饰MSC的损伤,设置对应的对照,通过CCK-8法、流式细胞术检测MSC的生长增殖以及凋亡情况;用Western blot测定MSC中与细胞凋亡有关的BCL-2蛋白的表达水平。结果表明,阿糖胞苷对基因修饰MSC的增殖抑制程度较未经基因修饰MSC明显减低,差异有统计学意义(p<0.05);去除阿糖胞苷后,基因修饰MSC的增殖生长能力在72小时后就开始恢复,而未经基因修饰MSC的增殖生长能力在72小时后仍然被抑制。在凋亡方面,阿糖胞苷诱导的基因修饰MSC的凋亡率明显降低(p<0.05),与未经基因修饰MSC相比,基因修饰MSC中BCL-2蛋白的表达上调(p<0.05)。结论:Wnt3a基因修饰能明显减轻阿糖胞苷对小鼠骨髓MSC的损伤作用。 This study was aimed to investigate the protective effect of Wit3a gene modification on mouse bone marrow mesenchymal stem cells aganist the injury induced by Ara-C. The gene-modified MSC steadily expressing Wnt3a were established by adenovirus system. The acute direct damage effects of different concentrations of Ara-C on the unmodified MSC and the gene-modified MSC were assessed by using an in vitro culture system, and the corresponding controls were set. The proliferation and apoptosis of MSC exposed to Ara-C were detected by cell count kit-8 (CCK-8) and flow cytometry. The expression of BCL-2 protein related with cell apoptosis was assayed by Western blot. The results indicated that as compared with unmodified MSC, Ara-C exhibited a less inhibitory effect on the proliferation of gene-modified MSC. There was obvious difference between unmodified MSC and gene-modified MSC (p 〈 0.05 ). The proliferation of gene-modifled MSC began to recover at 72 hours after removal of Ara-C. However, unmodified MSC showed sustained suppression of proliferation after withdrawal of Ara-C. In apoptosis, the apoptosis rate of gene-modified MSC induced by Ara-C was significantly lower than those of unmodified MSC (p 〈 0.05 ). In addition, the expression levels of BCL-2 protein in gene-modified MSC were up-regulated compared with unmodified MSC (p 〈 0.05). It is concluded that Wnt3a gene modification can significantly mitigate the damage of mouse bone marrow MSC induced by Ara-C.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第4期1033-1037,共5页 Journal of Experimental Hematology
关键词 Wnt3a基因 骨髓间充质干细胞 阿糖胞苷 Wnt3a gene bone marrow mesenchymal stem cell Ara-C damage
  • 相关文献

参考文献15

  • 1Le Blanc K, Ringd6n O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 2005 ; 11 ( 5 ) : 321 - 334.
  • 2Angelopoulou M, Novelli E, Grove JE, et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol, 2003; 31 (5) : 413 - 420.
  • 3Di Ianni M, Del Papa B, De Ioanni M, et al. Mesenchymal cells : a vehicle for gene therapy. Blood Cells Mol Dis, 2004 ; 33 ( 3 ) : 267 - 270.
  • 4Li J, Law HK, Lan YL, et al. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol, 2004; 127(3) : 326 -334.
  • 5Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene, 2009 ; 433 ( 1 - 2 ) : 1 - 7.
  • 6Neth P, Ciccarella M, Egea V, et al. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells, 2006; 24(8) : 1892 -1903.
  • 7Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy, 2009 ; 11 (5) : 503 - 515.
  • 8Baron F, Lechanteur C, Willems E, et al. Cotransplantation of mesenchymal stem ceils might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transplant, 2010; 16 (6) : 838 -847.
  • 9Braess J, Spiekermann K, Staib P, et al. Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG. Blood, 2009; 113(17) : 3903 -3910.
  • 10Huelsken J, Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev, 2001 ; 11 (5) : 547 - 553.

同被引文献51

  • 1梁辉,陈琳军,马静秋,刘晓莉.ATG用于异体造血干细胞移植前预防移植物抗宿主反应[J].上海交通大学学报(医学版),2007,27(8):1011-1013. 被引量:16
  • 2Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol, 2008, 8(9) :726-736.
  • 3Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005, 11 (5) : 389- 398.
  • 4Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002, 30 ( 1 ) : 42-48.
  • 5Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 2005, 105(7):281-287.
  • 6Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003, 102(10) :3837-3844.
  • 7Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene, 2009, 433(I-2) :1-7.
  • 8Gattinoni L, Zhong XS, Palmer DC, et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nature medicine, 2009, 15(7) :808-813.
  • 9Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood, 1996, 88(8) :3230-3239.
  • 10Aurelie T, Muriel S, Qizhi To Ex vivo-expanded CD4 + CD25 + immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T Cells. J Immunol, 2006, 176(2) : 1266 1273.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部